Human versus analogue insulin for children and young adults with type 1 diabetes in low-resource settings (HumAn-1): a multicentre, open-label, randomised controlled trial

Study limitation reported by the research below: “Open-label design is a methodological limitation; blinding of CGM data collection partially mitigates but does not eliminate bias.”